Cytokine expression in muscle following traumatic injury

Journal of Orthopaedic Research

Volumn 29, Issue 10, 2011, Pages 1613-1620

  Jackson, Wesley M ^a,b   Aragon, Amber B ^a,c   Onodera, Jun ^a   Koehler, Steven M ^a   Ji, Youngmi ^a   Bulken Hoover, Jamie D ^a,c   Vogler, Jared A ^a,b,c   Tuan, Rocky S ^a,d   Nesti, Leon J ^a,b,c  

^a Cartilage Biology and Orthopaedic Branch   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

bone morphogenetic protein; cytokines; gene expression profiling; heterotopic ossification; muscle injury

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; CHORDIN; CYTOKINE; GREMLIN; GROWTH DIFFERENTIATION FACTOR; GROWTH DIFFERENTIATION FACTOR 10; GROWTH DIFFERENTIATION FACTOR 11; INTERLEUKIN 15; MYOSTATIN; NOGGIN; PROCOLLAGEN C PROTEINASE; PROTEIN; PROTEIN NODAL; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE DEVELOPMENT; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; FIBROGENESIS; FIBROSIS; GENE EXPRESSION PROFILING; HETEROTOPIC OSSIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE INJURY; OSSIFYING MYOSITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADOLESCENT; ADULT; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SKELETAL; MYOSITIS OSSIFICANS; OSSIFICATION, HETEROTOPIC; SOFT TISSUE INJURIES; YOUNG ADULT;

EID: 80051549721     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21354     Document Type: Article

References (23)

1. Kaplan FS, Glaser DL, Hebela N, et al. 2004. Heterotopic ossification. J Am Acad Orthop Surg 12: 116-125.
2. Pape HC, Marsh S, Morley JR, et al. 2004. Current concepts in the development of heterotopic ossification. J Bone Joint Surg Br 86: 783-787. (Pubitemid 39173460)
3. Potter BK, Burns TC, Lacap AP, et al. 2007. Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am 89: 476-486. (Pubitemid 46365347)
4. Shore EM, Xu M, Feldman GJ, et al. 2006. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38: 525-527.
5. Shafritz AB, Shore EM, Gannon FH, et al. 1996. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335: 555-561. (Pubitemid 26272310)
6. Ahn J, Serrano delaPena L, Shore FS,., et al. 2003. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg Am 85-A: 667-674. (Pubitemid 36538716)
7. Shore EM, Kaplan FS,. 2008. Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone 43: 427-433.
8. Nesti LJ, Jackson WM, Shanti RM, et al. 2008. Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am 90: 2390-2398.
9. Jackson WM, Aragon AB, Djouad F, et al. 2009. Mesenchymal progenitor cells derived from traumatized human muscle. J Tissue Eng Regen Med 3: 129-138.
10. Jackson WM, Aragon AB, Nesti LJ, et al. 2009. Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res 27: 129-138.
11. Lounev VY, Ramachandran R, Wosczyna MN, et al. 2009. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 91: 652-663.
12. Beiner JM, Jokl P,. 2002. Muscle contusion injury and myositis ossificans traumatica. Clin Orthop Relat Res 403S: S110-S119. (Pubitemid 35345996)
13. Benjamini Y, Hochberg Y,. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57: 289-300.
14. Shah M, Foreman DM, Ferguson MW,. 1994. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107: 1137-1157.
15. Ge G, Greenspan DS,. 2006. Developmental roles of the BMP1/TLD metalloproteinases. Birth Defects Res C Embryo Today 78: 47-68. (Pubitemid 43726175)
16. Bock O, Hoftmann J, Theophile K, et al. 2008. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines. Am J Pathol 172: 951-960. (Pubitemid 351519992)
17. Smith CA, Stauber F, Waters C, et al. 2007. Transforming growth factor-beta following skeletal muscle strain injury in rats. J Appl Physiol 102: 755-761. (Pubitemid 46220908)
18. Bhowmick NA, Ghiassi M, Bakin A, et al. 2001. Transforming growth factor-{beta}1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12: 27-36. (Pubitemid 32060576)
19. Simionescu A, Simionescu DT, Vyavahare NR,. 2007. Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. Am J Pathol 171: 116-123. (Pubitemid 47339232)
20. Macdonald KK, Cheung CY, Anseth KS,. 2007. Cellular delivery of TGF-beta1 promotes osteoinductive signalling for bone regeneration. J Tissue Eng Regen Med 1: 314-317.
21. Shah M, Foreman DM, Ferguson MW,. 1995. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108: 985-1002.
22. Kirk S, Oldham J, Kambadur R, et al. 2000. Myostatin regulation during skeletal muscle regeneration. J Cell Physiol 184: 356-363. (Pubitemid 30625499)
23. Spiro RC, Thompson AY, Poser JW,. 2001. Spinal fusion with recombinant human growth and differentiation factor-5 combined with a mineralized collagen matrix. Anat Rec 263: 388-395. (Pubitemid 32730267)